临床经验
Copyright ©The Author(s) 2010.
世界华人消化杂志. 2010-04-28; 18(12): 1275-1279
在线出版 2010-04-28. doi: 10.11569/wcjd.v18.i12.1275
表2 联合基因型对CRC风险的修饰作用
联合基因型Y/N病例组F对照组FOR值(95%CI)P
APE1(V)-PARP1(V)-XRCC1(V)Y27261.428(0.784-2.600)0.243
N961321.000
APE1(V)-PARP1(V)-XRCC1(W)Y31430.901(0.527-1.542)0.704
N921151.000
APE1(V)-PARP1(W)-XRCC1(V)Y1582.604(1.066-6.361)0.031
N1081501.000
APE1(V)-PARP1(W)-XRCC1(W)Y13280.549(0.271-1.111)0.092
N1101301.000
APE1(W)-PARP1(V)-XRCC1(V)Y12180.771(0.357-1.666)0.508
N1211401.000
APE1(W)-PARP1(V)-XRCC1(W)Y12180.771(0.357-1.666)0.508
N1211401.000
APE1(W)-PARP1(W)-XRCC1(V)Y551.297(0.367-4.583)0.686
N1181531.000
APE1(W)-PARP1(W)-XRCC1(W)Y7110.806(0.303-2.145)0.666
N1161471.000

引文著录: 叶慈慈, 黄智铭, 周春燕. APE1 D148E、PARP1 V762A、XRCC1 R399Q的多态性与结直肠癌的易患性. 世界华人消化杂志 2010; 18(12): 1275-1279